We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SNG market cap is 14.09M. The company's latest EPS is GBP -0.0876 and P/E is -0.80.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 105k | 0 | 0 | 0 | 0 |
| Operating Income | -4.13M | -4.82M | -17.74M | -57.87M | -20.3M |
| Net Income | -3.3M | -3.89M | -13.92M | -48.66M | -17.65M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 6.8M | 4.07M | 88.55M | 44.64M | 23.53M |
| Total Liabilities | 777k | 1.82M | 3.41M | 7.64M | 3.25M |
| Total Equity | 6.03M | 2.25M | 85.14M | 37M | 20.28M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -3.82M | -2.9M | -23.82M | -41.02M | -14.29M |
| Investing | 1.59M | 66k | -45k | -21k | -3.62M |
| Financing | 2.67M | N/A | 96.39M | -112k | 1,000 |
| Market Cap | 14.09M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.88 |
| Price to Book Ratio | 0.7 |
| Dividend Yield | - |
| Shares Outstanding | 201.35M |
| Average Volume (1 week) | 171.62k |
| Average Volume (1 Month) | 210.46k |
| 52 Week Change | -28.24% |
| 52 Week High | 10.62 |
| 52 Week Low | 4.20 |
| Spread (Intraday) | 0.74 (9.87%) |
| Company Name | Synairgen Plc |
| Address |
mailpoint 810, level f southampton SO16 6YD |
| Website | https://www.synairgen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
